Clinical Trials Directory

Trials / Completed

CompletedNCT04909632

Tongue Fur and Metabolites in Diabetes Mellitus

Correlation Between Tongue Fur and Metabolites in Diabetes Mellitus and pre-diabetes-a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
China Medical University Hospital · Academic / Other
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Accepted

Summary

This study is a prospective cross-sectional study. The investigators enroll participants form the department of endocrinology and of metabolism, China Medical University Hospital. In total, 300 participants , composed of 100 of type 2 diabetes , 100 of pre-DM and 100 healthy participants. The investigators apply tongue diagnosis system, pulse wave analysis, body constitution questionnaires, and nailfold capillaroscopy to assess the differences of TCM diagnosis. After collecting the tongue coating and analyzing the metabolite signals with a flying mass spectrometer, The investigators collect the data to establish metabolite pattern and biomarkers. This study aims to identify the clinical symptoms of DM with TCM diagnostic tools and investigate the pattern difference and treatment for DM. Furtherly, the investigators add mass spectrometer to analyze the metabolites of tongue coating, the investigators propose to establish a metabolite pattern and biomarker to identify important biological indicators of DM.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLiquid chromatography-mass spectrometry (LC-MS) analysisThe data were acquired by UNIFI software (Waters) and processed by UNIFI and Progenesis QI software. Omics analysis methods, such as principal component analysis (PCA), partial least squares-discriminate analysis (PLS-DA), and orthogonal partial least squares-discriminate analysis (OPLS-DA), were employed to identify the biochemical patterns in tongue coating samples and suggest variables that can be used as biomarkers for diabetes and pre-diabetes.

Timeline

Start date
2020-03-01
Primary completion
2021-12-31
Completion
2022-07-31
First posted
2021-06-02
Last updated
2025-04-03

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04909632. Inclusion in this directory is not an endorsement.